GuidelineNeurosciences (Riyadh, Saudi Arabia)2025
Saudi clinical practice guidelines for the treatment and prevention of migraine headache.
Abstract readPractice Guideline
In one paragraph
Guideline in Neurosciences (Riyadh, Saudi Arabia), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Trends in migraine-specific medication consumption: a multinational analysis of 73 countries based on IQVIA-MIDAS database, 2015 to 2024.The journal of headache and pain · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Faisal A Al-Suwaidanfrom the Division of Neurology (Al-Suwaidan), Department of Medicine, Security Forces Hospital, Neurology Clinical Lead (Al-Suwaidan), Ministry of Health, from the College of Medicine (Al-Suwaidan), Princess Nourah Bint Abdulrahman University, from the College of Medicine (Al-Suwaidan), Dar Al-Uloom University, from Scientific Research Centre (Alotaibi, Alhazzani), Ministry of Defence Health Services, from the Department of Pharmaceutical Care Services (Al-Omari), Prince Sultan Military Medical City, from King Saud Medical City (Omaer), from Department of Family Medicine (Alrajhi), Administration of Anesthesiology & Perioperative Medicine (Alshoaiby), King Fahad Medical City, from the Colleges of Medicine and Pharmacy (Al-Jedai), Alfaisal University, from the Solid Organ Transplant (Al-Jedai), King Faisal Specialist Hospital & Research Centre, from The Saudi Society of Clinical Pharmacy (Al-Jedai, Almudaiheem), Riyadh, Saudi Arabia, and from the Department of Medicine (Al-Quliti), College of Medicine, Taibah University, National Guard Hospital, Madinah, and from Executive Management of Transformation, Planning, and Business Development (Alenzi), Tabuk Health Cluster, Tabuk, and from the Department of Neurology (Alabdali), College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Kingdom of Saudi Arabia.ORCID https://orcid.org/0000-0002-8742-7888
Hajer Y Almudaiheemfrom the Division of Neurology (Al-Suwaidan), Department of Medicine, Security Forces Hospital, Neurology Clinical Lead (Al-Suwaidan), Ministry of Health, from the College of Medicine (Al-Suwaidan), Princess Nourah Bint Abdulrahman University, from the College of Medicine (Al-Suwaidan), Dar Al-Uloom University, from Scientific Research Centre (Alotaibi, Alhazzani), Ministry of Defence Health Services, from the Department of Pharmaceutical Care Services (Al-Omari), Prince Sultan Military Medical City, from King Saud Medical City (Omaer), from Department of Family Medicine (Alrajhi), Administration of Anesthesiology & Perioperative Medicine (Alshoaiby), King Fahad Medical City, from the Colleges of Medicine and Pharmacy (Al-Jedai), Alfaisal University, from the Solid Organ Transplant (Al-Jedai), King Faisal Specialist Hospital & Research Centre, from The Saudi Society of Clinical Pharmacy (Al-Jedai, Almudaiheem), Riyadh, Saudi Arabia, and from the Department of Medicine (Al-Quliti), College of Medicine, Taibah University, National Guard Hospital, Madinah, and from Executive Management of Transformation, Planning, and Business Development (Alenzi), Tabuk Health Cluster, Tabuk, and from the Department of Neurology (Alabdali), College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Kingdom of Saudi Arabia.
Haifa F Alotaibifrom the Division of Neurology (Al-Suwaidan), Department of Medicine, Security Forces Hospital, Neurology Clinical Lead (Al-Suwaidan), Ministry of Health, from the College of Medicine (Al-Suwaidan), Princess Nourah Bint Abdulrahman University, from the College of Medicine (Al-Suwaidan), Dar Al-Uloom University, from Scientific Research Centre (Alotaibi, Alhazzani), Ministry of Defence Health Services, from the Department of Pharmaceutical Care Services (Al-Omari), Prince Sultan Military Medical City, from King Saud Medical City (Omaer), from Department of Family Medicine (Alrajhi), Administration of Anesthesiology & Perioperative Medicine (Alshoaiby), King Fahad Medical City, from the Colleges of Medicine and Pharmacy (Al-Jedai), Alfaisal University, from the Solid Organ Transplant (Al-Jedai), King Faisal Specialist Hospital & Research Centre, from The Saudi Society of Clinical Pharmacy (Al-Jedai, Almudaiheem), Riyadh, Saudi Arabia, and from the Department of Medicine (Al-Quliti), College of Medicine, Taibah University, National Guard Hospital, Madinah, and from Executive Management of Transformation, Planning, and Business Development (Alenzi), Tabuk Health Cluster, Tabuk, and from the Department of Neurology (Alabdali), College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Kingdom of Saudi Arabia.
Waleed A Alhazzanifrom the Division of Neurology (Al-Suwaidan), Department of Medicine, Security Forces Hospital, Neurology Clinical Lead (Al-Suwaidan), Ministry of Health, from the College of Medicine (Al-Suwaidan), Princess Nourah Bint Abdulrahman University, from the College of Medicine (Al-Suwaidan), Dar Al-Uloom University, from Scientific Research Centre (Alotaibi, Alhazzani), Ministry of Defence Health Services, from the Department of Pharmaceutical Care Services (Al-Omari), Prince Sultan Military Medical City, from King Saud Medical City (Omaer), from Department of Family Medicine (Alrajhi), Administration of Anesthesiology & Perioperative Medicine (Alshoaiby), King Fahad Medical City, from the Colleges of Medicine and Pharmacy (Al-Jedai), Alfaisal University, from the Solid Organ Transplant (Al-Jedai), King Faisal Specialist Hospital & Research Centre, from The Saudi Society of Clinical Pharmacy (Al-Jedai, Almudaiheem), Riyadh, Saudi Arabia, and from the Department of Medicine (Al-Quliti), College of Medicine, Taibah University, National Guard Hospital, Madinah, and from Executive Management of Transformation, Planning, and Business Development (Alenzi), Tabuk Health Cluster, Tabuk, and from the Department of Neurology (Alabdali), College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Kingdom of Saudi Arabia.
Khalid W Al-Qulitifrom the Division of Neurology (Al-Suwaidan), Department of Medicine, Security Forces Hospital, Neurology Clinical Lead (Al-Suwaidan), Ministry of Health, from the College of Medicine (Al-Suwaidan), Princess Nourah Bint Abdulrahman University, from the College of Medicine (Al-Suwaidan), Dar Al-Uloom University, from Scientific Research Centre (Alotaibi, Alhazzani), Ministry of Defence Health Services, from the Department of Pharmaceutical Care Services (Al-Omari), Prince Sultan Military Medical City, from King Saud Medical City (Omaer), from Department of Family Medicine (Alrajhi), Administration of Anesthesiology & Perioperative Medicine (Alshoaiby), King Fahad Medical City, from the Colleges of Medicine and Pharmacy (Al-Jedai), Alfaisal University, from the Solid Organ Transplant (Al-Jedai), King Faisal Specialist Hospital & Research Centre, from The Saudi Society of Clinical Pharmacy (Al-Jedai, Almudaiheem), Riyadh, Saudi Arabia, and from the Department of Medicine (Al-Quliti), College of Medicine, Taibah University, National Guard Hospital, Madinah, and from Executive Management of Transformation, Planning, and Business Development (Alenzi), Tabuk Health Cluster, Tabuk, and from the Department of Neurology (Alabdali), College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Kingdom of Saudi Arabia.
Khalidah A Alenzifrom the Division of Neurology (Al-Suwaidan), Department of Medicine, Security Forces Hospital, Neurology Clinical Lead (Al-Suwaidan), Ministry of Health, from the College of Medicine (Al-Suwaidan), Princess Nourah Bint Abdulrahman University, from the College of Medicine (Al-Suwaidan), Dar Al-Uloom University, from Scientific Research Centre (Alotaibi, Alhazzani), Ministry of Defence Health Services, from the Department of Pharmaceutical Care Services (Al-Omari), Prince Sultan Military Medical City, from King Saud Medical City (Omaer), from Department of Family Medicine (Alrajhi), Administration of Anesthesiology & Perioperative Medicine (Alshoaiby), King Fahad Medical City, from the Colleges of Medicine and Pharmacy (Al-Jedai), Alfaisal University, from the Solid Organ Transplant (Al-Jedai), King Faisal Specialist Hospital & Research Centre, from The Saudi Society of Clinical Pharmacy (Al-Jedai, Almudaiheem), Riyadh, Saudi Arabia, and from the Department of Medicine (Al-Quliti), College of Medicine, Taibah University, National Guard Hospital, Madinah, and from Executive Management of Transformation, Planning, and Business Development (Alenzi), Tabuk Health Cluster, Tabuk, and from the Department of Neurology (Alabdali), College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Kingdom of Saudi Arabia.
Bedor A Al-Omarifrom the Division of Neurology (Al-Suwaidan), Department of Medicine, Security Forces Hospital, Neurology Clinical Lead (Al-Suwaidan), Ministry of Health, from the College of Medicine (Al-Suwaidan), Princess Nourah Bint Abdulrahman University, from the College of Medicine (Al-Suwaidan), Dar Al-Uloom University, from Scientific Research Centre (Alotaibi, Alhazzani), Ministry of Defence Health Services, from the Department of Pharmaceutical Care Services (Al-Omari), Prince Sultan Military Medical City, from King Saud Medical City (Omaer), from Department of Family Medicine (Alrajhi), Administration of Anesthesiology & Perioperative Medicine (Alshoaiby), King Fahad Medical City, from the Colleges of Medicine and Pharmacy (Al-Jedai), Alfaisal University, from the Solid Organ Transplant (Al-Jedai), King Faisal Specialist Hospital & Research Centre, from The Saudi Society of Clinical Pharmacy (Al-Jedai, Almudaiheem), Riyadh, Saudi Arabia, and from the Department of Medicine (Al-Quliti), College of Medicine, Taibah University, National Guard Hospital, Madinah, and from Executive Management of Transformation, Planning, and Business Development (Alenzi), Tabuk Health Cluster, Tabuk, and from the Department of Neurology (Alabdali), College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Kingdom of Saudi Arabia.
Majed M Alabdalifrom the Division of Neurology (Al-Suwaidan), Department of Medicine, Security Forces Hospital, Neurology Clinical Lead (Al-Suwaidan), Ministry of Health, from the College of Medicine (Al-Suwaidan), Princess Nourah Bint Abdulrahman University, from the College of Medicine (Al-Suwaidan), Dar Al-Uloom University, from Scientific Research Centre (Alotaibi, Alhazzani), Ministry of Defence Health Services, from the Department of Pharmaceutical Care Services (Al-Omari), Prince Sultan Military Medical City, from King Saud Medical City (Omaer), from Department of Family Medicine (Alrajhi), Administration of Anesthesiology & Perioperative Medicine (Alshoaiby), King Fahad Medical City, from the Colleges of Medicine and Pharmacy (Al-Jedai), Alfaisal University, from the Solid Organ Transplant (Al-Jedai), King Faisal Specialist Hospital & Research Centre, from The Saudi Society of Clinical Pharmacy (Al-Jedai, Almudaiheem), Riyadh, Saudi Arabia, and from the Department of Medicine (Al-Quliti), College of Medicine, Taibah University, National Guard Hospital, Madinah, and from Executive Management of Transformation, Planning, and Business Development (Alenzi), Tabuk Health Cluster, Tabuk, and from the Department of Neurology (Alabdali), College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Kingdom of Saudi Arabia.
Abubker W Omaerfrom the Division of Neurology (Al-Suwaidan), Department of Medicine, Security Forces Hospital, Neurology Clinical Lead (Al-Suwaidan), Ministry of Health, from the College of Medicine (Al-Suwaidan), Princess Nourah Bint Abdulrahman University, from the College of Medicine (Al-Suwaidan), Dar Al-Uloom University, from Scientific Research Centre (Alotaibi, Alhazzani), Ministry of Defence Health Services, from the Department of Pharmaceutical Care Services (Al-Omari), Prince Sultan Military Medical City, from King Saud Medical City (Omaer), from Department of Family Medicine (Alrajhi), Administration of Anesthesiology & Perioperative Medicine (Alshoaiby), King Fahad Medical City, from the Colleges of Medicine and Pharmacy (Al-Jedai), Alfaisal University, from the Solid Organ Transplant (Al-Jedai), King Faisal Specialist Hospital & Research Centre, from The Saudi Society of Clinical Pharmacy (Al-Jedai, Almudaiheem), Riyadh, Saudi Arabia, and from the Department of Medicine (Al-Quliti), College of Medicine, Taibah University, National Guard Hospital, Madinah, and from Executive Management of Transformation, Planning, and Business Development (Alenzi), Tabuk Health Cluster, Tabuk, and from the Department of Neurology (Alabdali), College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Kingdom of Saudi Arabia.
Saleh M Alrajhifrom the Division of Neurology (Al-Suwaidan), Department of Medicine, Security Forces Hospital, Neurology Clinical Lead (Al-Suwaidan), Ministry of Health, from the College of Medicine (Al-Suwaidan), Princess Nourah Bint Abdulrahman University, from the College of Medicine (Al-Suwaidan), Dar Al-Uloom University, from Scientific Research Centre (Alotaibi, Alhazzani), Ministry of Defence Health Services, from the Department of Pharmaceutical Care Services (Al-Omari), Prince Sultan Military Medical City, from King Saud Medical City (Omaer), from Department of Family Medicine (Alrajhi), Administration of Anesthesiology & Perioperative Medicine (Alshoaiby), King Fahad Medical City, from the Colleges of Medicine and Pharmacy (Al-Jedai), Alfaisal University, from the Solid Organ Transplant (Al-Jedai), King Faisal Specialist Hospital & Research Centre, from The Saudi Society of Clinical Pharmacy (Al-Jedai, Almudaiheem), Riyadh, Saudi Arabia, and from the Department of Medicine (Al-Quliti), College of Medicine, Taibah University, National Guard Hospital, Madinah, and from Executive Management of Transformation, Planning, and Business Development (Alenzi), Tabuk Health Cluster, Tabuk, and from the Department of Neurology (Alabdali), College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Kingdom of Saudi Arabia.
Ali N Alshoaibyfrom the Division of Neurology (Al-Suwaidan), Department of Medicine, Security Forces Hospital, Neurology Clinical Lead (Al-Suwaidan), Ministry of Health, from the College of Medicine (Al-Suwaidan), Princess Nourah Bint Abdulrahman University, from the College of Medicine (Al-Suwaidan), Dar Al-Uloom University, from Scientific Research Centre (Alotaibi, Alhazzani), Ministry of Defence Health Services, from the Department of Pharmaceutical Care Services (Al-Omari), Prince Sultan Military Medical City, from King Saud Medical City (Omaer), from Department of Family Medicine (Alrajhi), Administration of Anesthesiology & Perioperative Medicine (Alshoaiby), King Fahad Medical City, from the Colleges of Medicine and Pharmacy (Al-Jedai), Alfaisal University, from the Solid Organ Transplant (Al-Jedai), King Faisal Specialist Hospital & Research Centre, from The Saudi Society of Clinical Pharmacy (Al-Jedai, Almudaiheem), Riyadh, Saudi Arabia, and from the Department of Medicine (Al-Quliti), College of Medicine, Taibah University, National Guard Hospital, Madinah, and from Executive Management of Transformation, Planning, and Business Development (Alenzi), Tabuk Health Cluster, Tabuk, and from the Department of Neurology (Alabdali), College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Kingdom of Saudi Arabia.
Ahmed H Al-Jedaifrom the Division of Neurology (Al-Suwaidan), Department of Medicine, Security Forces Hospital, Neurology Clinical Lead (Al-Suwaidan), Ministry of Health, from the College of Medicine (Al-Suwaidan), Princess Nourah Bint Abdulrahman University, from the College of Medicine (Al-Suwaidan), Dar Al-Uloom University, from Scientific Research Centre (Alotaibi, Alhazzani), Ministry of Defence Health Services, from the Department of Pharmaceutical Care Services (Al-Omari), Prince Sultan Military Medical City, from King Saud Medical City (Omaer), from Department of Family Medicine (Alrajhi), Administration of Anesthesiology & Perioperative Medicine (Alshoaiby), King Fahad Medical City, from the Colleges of Medicine and Pharmacy (Al-Jedai), Alfaisal University, from the Solid Organ Transplant (Al-Jedai), King Faisal Specialist Hospital & Research Centre, from The Saudi Society of Clinical Pharmacy (Al-Jedai, Almudaiheem), Riyadh, Saudi Arabia, and from the Department of Medicine (Al-Quliti), College of Medicine, Taibah University, National Guard Hospital, Madinah, and from Executive Management of Transformation, Planning, and Business Development (Alenzi), Tabuk Health Cluster, Tabuk, and from the Department of Neurology (Alabdali), College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Kingdom of Saudi Arabia.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo develop clinical practice guidelines based on evidence based medicine on the use of abortive and preventive therapies for managing migraine headaches. We formulated these guidelines to offer evidence-based recommendations to improve the knowledge of physicians, healthcare professionals, and policymakers in migraine headache management.
methodA panel of 11 experts from different sectors in Saudi Arabia approved 26 questions on abortive and preventive therapies for migraines. To develop each question, we searched "PubMed" and "Cochrane Library" databases for recent relevant systematic reviews published between 2013 and 2024. We employed the Grading Recommendations, Assessment, Development, and Evaluation methodological approach to ensure the certainty of the collated evidence and to formulate the recommendations. The expert panel voted electronically on each recommendation, and a consensus was defined as >70% agreement.
resultsWe formulated a total of 26 recommendations. Of these, 14 are focused on abortive therapy for acute migraine attacks, whereas 12 are focused on the prevention of episodic or chronic migraines. These guidelines strongly recommend the use of paracetamol and ibuprofen as the first-line treatment for mild to moderate migraine. Furthermore, we concluded that propranolol should be considered as the first-line preventive intervention for migraine.
conclusionThe Saudi clinical practice guidelines offer systematically validated recommendations of migraine headaches in adults. The recommendations are potentially beneficial for all healthcare professionals managing patients with migraine headaches.
Indexed as
Migraine DisordersEvidence-Based MedicineHumansSaudi Arabia
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.